Certified Hospice and Palliative Assistant (CHPNA) Practice Test 2025 – All-in-One Study Resource for Exam Success!

Neoadjuvant therapy refers to treatment that is administered before the primary treatment for a disease, most commonly in cancer care. This approach is often employed to reduce the size of a tumor or to control the spread of cancer before surgical intervention. The goal is to make the primary treatment more effective, potentially leading to less extensive surgery or improved outcomes post-surgery.

In the context of cancer treatment, neoadjuvant therapy could involve chemotherapy, radiation therapy, or hormonal therapy given prior to the main intervention. Its use is particularly important in cases where immediate surgical removal of a tumor is not possible or could lead to greater risks.

Understanding this concept is critical for healthcare professionals working in palliative care and hospice settings, as recognizing the role of neoadjuvant therapy can influence patient discussions and treatment planning. This insight allows for better communication regarding patient expectations and goals of care, especially when considering how therapies intersect with palliative treatments.